🇺🇸 FDA
Patent

US 9120867

Lutzomyia longipalpis polypeptides and methods of use

granted A61KA61K2039/53A61K2039/57

Quick answer

US patent 9120867 (Lutzomyia longipalpis polypeptides and methods of use) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Aug 27 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Sep 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 27 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K2039/53, A61K2039/57, A61K2039/575, A61K2039/58